Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Ross

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Blood Cancer Journal|March 18, 2014
Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patientsB A Walker, C P Wardell, A Brioli, et al.
Nature Communications|September 15, 2022
Control of structure and spin texture in the van der Waals layered magnet CrSBrJ Klein, T Pham, J D Thomsen, et al.
Leukemia|July 2, 2005
Age has a profound effect on the incidence and significance of chromosome abnormalities in myelomaF M Ross, A H Ibrahim, A Vilain-Holmes, et al.
British Journal of Haematology|February 13, 2001
Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemiaD Rowe, S J Cotterill, F M Ross, et al.
Leukemia|July 11, 2006
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myelomaL Chiecchio, R K M Protheroe, A H Ibrahim, et al.
Oncogene|January 24, 2007
Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridizationJ C Strefford, H Worley, K Barber, et al.
Leukemia|August 13, 2011
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trialK D Boyd, F M Ross, L Chiecchio, et al.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Blood Cancer Journal|March 18, 2014
Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patientsB A Walker, C P Wardell, A Brioli, et al.
Nature Communications|September 15, 2022
Control of structure and spin texture in the van der Waals layered magnet CrSBrJ Klein, T Pham, J D Thomsen, et al.
Leukemia|July 2, 2005
Age has a profound effect on the incidence and significance of chromosome abnormalities in myelomaF M Ross, A H Ibrahim, A Vilain-Holmes, et al.
British Journal of Haematology|February 13, 2001
Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemiaD Rowe, S J Cotterill, F M Ross, et al.
Leukemia|July 11, 2006
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myelomaL Chiecchio, R K M Protheroe, A H Ibrahim, et al.
Oncogene|January 24, 2007
Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridizationJ C Strefford, H Worley, K Barber, et al.
Leukemia|August 13, 2011
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trialK D Boyd, F M Ross, L Chiecchio, et al.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Pageof 8